Drug Trial Radar · NCT00091949
Insulin Resistance Intervention After Stroke Trial
Last checked: Nov 20, 2026Latest source record: Apr 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,876
Actual
Start
Feb 2005
Primary completion
Nov 2015
Study completion Nov 2015
Sponsor
- Lead sponsor
- Yale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS); Takeda Pharmaceuticals North America, Inc.
- First posted
- Sep 22, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.
Conditions
- Stroke
- Myocardial Infarction
- Diabetes
Interventions
pioglitazoneDrug
a thiazolidinedione drug
placeboDrug
an inactive substance
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recurrent Fatal or Non-fatal Stroke, or Fatal or Non-fatal Myocardial InfarctionTime frame: Up to 5 years
Locations
183 sites in 8 countries. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
University of South Alabama
Mobile, Alabama
University of Arizona
Tucson, Arizona
Shanti Clinical Trials (NINDS-CRC site)
Colton, California
UCSF-Fresno
Fresno, California
Scripps Clinic
La Jolla, California
University of Southern California
Los Angeles, California
University of California
Los Angeles, California
Stanford University
Palo Alto, California
University of California-Davis
Sacramento, California
University of California
San Diego, California
University of California
San Francisco, California
Denver Health and Hospital Authority
Denver, Colorado
Hartford
Hartford, Connecticut
Yale University
New Haven, Connecticut
National Rehabilitation Hospital
Washington D.C., District of Columbia
University of Florida
Gainesville, Florida
University of Florida
Jacksonville, Florida
MIMA Century Research Associates
Melbourne, Florida
Pines Neurological Associates (NINDS-CRC site)
Pembroke Pines, Florida
Floria Neurovascular Institute
Tampa, Florida
Cook County (Stroger) Hospital
Chicago, Illinois
Rush University
Chicago, Illinois
University of Illinois
Chicago, Illinois
Ingalls Memorial Hospital (NINDS-CRC site)
Harvey, Illinois
Loyola University Medical Center
Maywood, Illinois
OSF St. Francis Medical Center
Peoria, Illinois
Tri-City Neruology (NINDS-CRC site)
Saint Charles, Illinois
Indiana Medical Research
Elkhart, Indiana
Associates In Neurology (NINDS-CRC site)
Valparaiso, Indiana
Iowa Health Des Moines Clinical Trials Office
Des Moines, Iowa
Ruan Neuroscience Center/Mercy Medical Center
Des Moines, Iowa
University of Iowa
Iowa City, Iowa
Northeast Iowa Medical Education Foundation (NINDS-CRC site)
Waterloo, Iowa
Via Christi Regional Medical Center
Wichita, Kansas
University of Kentucky Research Foundation
Lexington, Kentucky
Louisiana State University Health Sciences Center
Shreveport, Louisiana
Penobscot Bay Neurology
Rockport, Maine
Sinai Hospital of Baltimore
Baltimore, Maryland
Johns Hopkins
Baltimore, Maryland
Showing 40 of 183 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.